Xuewen Tan

532 total citations
9 papers, 399 citations indexed

About

Xuewen Tan is a scholar working on Cancer Research, Oncology and Immunology. According to data from OpenAlex, Xuewen Tan has authored 9 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Xuewen Tan's work include Immune cells in cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Xuewen Tan is often cited by papers focused on Immune cells in cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Xuewen Tan collaborates with scholars based in China and Saint Kitts and Nevis. Xuewen Tan's co-authors include Jiajie Tu, Yilong Fang, Wenming Hong, Wei Wei, Dafei Han, Haifeng Jiang, Yizhao Chen, Xinming Wang, Zhiying Yu and Xun Gong and has published in prestigious journals such as Oncogene, Annals of the Rheumatic Diseases and Biomedicine & Pharmacotherapy.

In The Last Decade

Xuewen Tan

9 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuewen Tan China	8	177	162	148	82	66	9	399
Dávid Győri Hungary	11	244 1.4×	228 1.4×	227 1.5×	46 0.6×	61 0.9×	16	526
Mariela A. Moreno Ayala Argentina	10	154 0.9×	194 1.2×	140 0.9×	42 0.5×	47 0.7×	14	379
Victoria Saferding Austria	10	248 1.4×	186 1.1×	93 0.6×	55 0.7×	92 1.4×	24	451
Michael Zepp Germany	13	179 1.0×	109 0.7×	162 1.1×	32 0.4×	67 1.0×	25	386
Dilip Kumar Singapore	8	131 0.7×	187 1.2×	70 0.5×	19 0.2×	99 1.5×	15	351
L Danks United Kingdom	5	213 1.2×	55 0.3×	176 1.2×	85 1.0×	43 0.7×	7	379
Nathalie Amiable Canada	9	206 1.2×	68 0.4×	94 0.6×	168 2.0×	65 1.0×	14	417
Chengyu Lv China	12	162 0.9×	54 0.3×	101 0.7×	33 0.4×	62 0.9×	28	382
Simon Dai United States	7	281 1.6×	75 0.5×	149 1.0×	34 0.4×	199 3.0×	7	369
Shuier Zheng China	13	269 1.5×	94 0.6×	144 1.0×	32 0.4×	109 1.7×	31	431

Countries citing papers authored by Xuewen Tan

Since Specialization

Citations

This map shows the geographic impact of Xuewen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewen Tan more than expected).

Fields of papers citing papers by Xuewen Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewen Tan. The network helps show where Xuewen Tan may publish in the future.

Co-authorship network of co-authors of Xuewen Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuewen Tan. A scholar is included among the top collaborators of Xuewen Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuewen Tan. Xuewen Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fang, Yilong, Huihui Wang, Xuewen Tan, et al.. (2023). Role of chemokine receptor 2 in rheumatoid arthritis: A research update. International Immunopharmacology. 116. 109755–109755. 8 indexed citations

2.

Fang, Yilong, Dafei Han, Xuewen Tan, et al.. (2022). MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses. Oncogene. 41(17). 2444–2457. 7 indexed citations

3.

Tu, Jiajie, Yilong Fang, Dafei Han, et al.. (2022). PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes. Annals of the Rheumatic Diseases. 82(2). 198–211. 45 indexed citations

4.

Tu, Jiajie, Xuewen Tan, Yu Chen, et al.. (2022). Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages. Cancer Science. 113(8). 2496–2512. 19 indexed citations

5.

Tu, Jiajie, Dafei Han, Yilong Fang, et al.. (2021). MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes. Molecular Therapy — Nucleic Acids. 27. 733–750. 12 indexed citations

6.

Chen, Yizhao, Zhiying Yu, Xuewen Tan, et al.. (2021). CAR-macrophage: A new immunotherapy candidate against solid tumors. Biomedicine & Pharmacotherapy. 139. 111605–111605. 185 indexed citations

7.

Tan, Xuewen, Haifeng Jiang, Yilong Fang, et al.. (2020). The essential role of long non-coding RNA GAS5 in glioma: interaction with microRNAs, chemosensitivity and potential as a biomarker. Journal of Cancer. 12(1). 224–231. 14 indexed citations

8.

Han, Dafei, Yilong Fang, Xuewen Tan, et al.. (2020). The emerging role of fibroblast‐like synoviocytes‐mediated synovitis in osteoarthritis: An update. Journal of Cellular and Molecular Medicine. 24(17). 9518–9532. 90 indexed citations

9.

Tu, Jiajie, Yilong Fang, Dafei Han, et al.. (2020). Activation of nuclear factor‐κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies. Cell Proliferation. 54(2). e12929–e12929. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact